335
Participants
Start Date
August 17, 2022
Primary Completion Date
August 11, 2023
Study Completion Date
August 14, 2023
Test Product - Tiotropium Bromide Inhalation Powder 18 mcg
Test Product
Spiriva Handihaler (Tiotropium Bromide) 18 mcg
RLD
Placebo
Placebo Product
Velocity clinical Research Syracuse (East North)), Syracuse
Velocity Clinical Research Columbia, Columbia
Velocity Clinical Research Spartanburg, Spartanburg
Velocity Clinical Research Gaffney, Gaffney
Velocity Clinical Research Union, Union
Velocity Clinical Research Greenville, Greenville
Velocity Clinical Research Anderson, Anderson
Velocity Clinical Research - New Smyrna Beach, New Smyrna Beach
SIMED Health, Gainesville
Clintex Research Group, Inc., Miami
Research Institue of South Florida, Miami
Vista Health Research, Miami
Southwest General Heathcare, Fort Myers
Clinical Research Solutions, Kissimmee
Velocity Clinical Research-Cincinnati, Cincinnati
Southern Clinical Research, Zachary
Inquest Clinical Research, Cypress
Mt. Olympus Medical Research, Houston
Sante Clinical Research, Kerrville
Velocity Clinical Research-Utah, West Jordan
DownTown LA Research (West Coast), Los Angeles
Velocity Clinical Research Medford, Medford
Velocity Clinical Research Grants Pass (W Coast), Grants Pass
Greater Providence Clinical Research (East North), Cranston
Anand Surgical Hospital Pvt. Ltd, Ahmedabad
Care and Cure Multispeciality Hospital, Ahmedabad
Hope Medicare Centre, Ahmedabad
Divine Multispeciality Hopsital, Gandhinagar
Maharaja Agrasen Superspeciality Hospital, Jaipur
Shree Hospital & Critical Care Centre, Nagpur
Chest Disease Hospital, Srinagar
Global Hospital, Surat
Dhawal Multispeciality Hospital, Vadodara
Collaborators (2)
Exeltis
INDUSTRY
Laboratorios Liconsa
INDUSTRY
Xiromed LLC
INDUSTRY